Generic drug company of Woodcliff,NJ is down -0.87 after blowing away estimates
Sad thing is that 1M shares short the stock could have easily sent it to $25+ today had an analyst put out a timely upgrade. Looks like the analysts and their clients want in cheaper at $22 before they start pumping their shares.
918.29MRevenue Per Share (ttm):27.421Qtrly Revenue Growth (yoy):257.70%Gross Profit (ttm):176.57MEBITDA (ttm):109.75MNet Income Avl to Common (ttm):13.90MDiluted EPS (ttm):0.36Qtrly Earnings Growth (yoy): N/A Balance Sheet
Total Cash (mrq):202.34MTotal Cash Per Share (mrq):5.82Total Debt (mrq):120.04MTotal Debt/Equity (mrq):N/ACurrent Ratio (mrq):2.221Book Value Per Share (mrq):13.633 Cash Flow Statement
Operating Cash Flow (ttm):47.17MLevered Free Cash Flow (ttm):34.26M